[{"NetIncomeLoss_1_Q2_USD":-8497000.0,"MarketableSecuritiesCurrent_0_Q2_USD":88223000.0,"DebtWeightedAverageInterestRate_0_Q2_pure":0.117,"CommonStockDividendsPerShareDeclared_2_Q2_USD":0.0,"DeferredRentCreditCurrent_0_Q2_USD":218000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":22259047.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":23330918.0,"CommitmentsAndContingencies_0_Q2_USD":null,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":5013000.0,"OperatingLeasesRentExpenseNet_2_Q2_USD":1000000.0,"OperatingLeasesRentExpenseNet_1_Q2_USD":500000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":36000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":7000000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-28009000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":75042000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":1000.0,"AssetsCurrent_0_Q2_USD":158227000.0,"LongTermDebtCurrent_0_Q2_USD":0.0,"EquityMethodInvestmentOwnershipPercentage_0_Q2_pure":1.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":324000.0,"ShareBasedCompensation_2_Q2_USD":1016000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-191000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":38000.0,"Assets_0_Q2_USD":163137000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":88223000.0,"CommonStockSharesIssued_0_Q2_shares":27136362.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":92000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":2328665.0,"DebtInstrumentUnamortizedDiscount_0_Q2_USD":990000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":5867000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":12519000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":959000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-149000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":64000.0,"Liabilities_0_Q2_USD":49377000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":745000.0,"Revenues_1_Q2_USD":3391000.0,"Revenues_2_Q2_USD":10921000.0,"CommonStockValue_0_Q2_USD":500556000.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q2_USD":1948000.0,"AccountsReceivableNetCurrent_0_Q2_USD":4431000.0,"RevenueRemainingPerformanceObligation_0_Q2_USD":2900000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":371000.0,"ProceedsFromStockPlans_2_Q2_USD":197000.0,"AssetsFairValueDisclosure_0_Q2_USD":124929000.0,"OperatingLeasesFutureMinimumPaymentsDueThereafter_0_Q2_USD":6452000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":89000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":3903000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":10128000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":588000.0,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"ForeignCurrencyTransactionGainLossUnrealized_2_Q2_USD":131000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q2_USD":631000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":51152000.0,"OtherAssetsNoncurrent_0_Q2_USD":6000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-3827000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-8688000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-17311000.0,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q2_USD":646000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":75695000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":8858000.0,"IncreaseDecreaseInDeferredCharges_2_Q2_USD":-623000.0,"FairValueAdjustmentOfWarrants_1_Q2_USD":0.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":139400000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":36025000.0,"CommonStockNoParValue_0_Q2_USD":null,"PaymentsOfStockIssuanceCosts_2_Q2_USD":339000.0,"IncreaseDecreaseInInventories_2_Q2_USD":1409000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":12166000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":3923000.0,"OperatingIncomeLoss_2_Q2_USD":-15878000.0,"InterestExpense_2_Q2_USD":2043000.0,"NonoperatingIncomeExpense_1_Q2_USD":-630000.0,"NonoperatingIncomeExpense_2_Q2_USD":-1455000.0,"AccountsPayableCurrent_0_Q2_USD":3722000.0,"LiabilitiesCurrent_0_Q2_USD":13818000.0,"CostOfRevenue_1_Q2_USD":1482000.0,"InterestExpense_1_Q2_USD":1001000.0,"CostOfRevenue_2_Q2_USD":4152000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":6583000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-16715000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-42000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-26000.0,"OperatingLeasesFutureMinimumPaymentsDueInFourYears_0_Q2_USD":1997000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":119000.0,"CommonStockDividendsPerShareCashPaid_2_Q2_USD":0.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q2_USD":1900000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":51652000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":167000.0,"NetIncomeLoss_2_Q2_USD":-17349000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":4404000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q2_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_2_Q2_USD":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":47000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":1866000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1_Q2_USD":628000.0,"PreferredStockNoParValue_0_Q2_USD":null,"GrossProfit_1_Q2_USD":1909000.0,"GrossProfit_2_Q2_USD":6769000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":1715000.0,"LongTermDebtNoncurrent_0_Q2_USD":34395000.0,"NoncurrentAssets_0_Q2_USD":4404000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":848000.0,"DebtInstrumentInterestRateEffectivePercentage_0_Q2_pure":0.1,"RestrictedCashNoncurrent_0_Q2_USD":500000.0,"OperatingExpenses_1_Q2_USD":9770000.0,"OperatingExpenses_2_Q2_USD":22647000.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":49000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":631000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":1016000.0,"PreferredStockSharesAuthorized_0_Q2_shares":25000000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":660000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":3441000.0,"PreferredStockValue_0_Q2_USD":null,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":1020000.0,"InventoryNet_0_Q2_USD":12555000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":-8491000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":-17333000.0,"OperatingIncomeLoss_1_Q2_USD":-7861000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":163137000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":63637000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.78,"ProfitLoss_2_Q2_USD":-17349000.0,"CommonStockSharesOutstanding_0_Q2_shares":27136362.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-2135000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":31060000.0,"CurrentIncomeTaxExpenseBenefit_1_Q2_USD":6000.0,"CurrentIncomeTaxExpenseBenefit_2_Q2_USD":16000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-386832000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.36,"OperatingLeasesFutureMinimumPaymentsDueInFiveYears_0_Q2_USD":2047000.0,"RestrictedCashAndCashEquivalents_0_Q2_USD":500000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":88105000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":35000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":397000.0,"StockholdersEquity_0_Q2_USD":113760000.0,"DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_0_Q2_USD":385000.0,"DeferredRentCreditNoncurrent_0_Q2_USD":1164000.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q2_USD":14990000.0,"Ticker":"TMDX","CIK":"1756262","name":"TRANSMEDICS GROUP, INC.","OfficialName":"TransMedics Group Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"632779019.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]